GLP‑1 agonists: miracle drugs for metabolic syndrome, but who can afford them?
Ozempic, Wegovy, Mounjaro — you've heard the hype. These GLP‑1 agonists were diabetes drugs, but they cause dramatic weight loss and improve every component of metabolic syndrome. The metabolic syndrome market research study shows that the pharmaceutical segment is the largest by far, driven by these blockbusters. But here's the rub: they cost $1,000+ per month, and many...
0 Comments 0 Shares 6 Views 0 Reviews
MakeMyFriends https://makemyfriends.com